Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent

Area of Science:

• Cardiovascular medicine
• Biomaterials engineering
• Interventional cardiology

Background:

• Coronary stent technology has evolved, enhancing percutaneous coronary intervention (PCI) safety and efficacy.
• Drug-eluting stents (DES) are widely used but associated with risks like delayed healing and late stent thrombosis.
• Bare metal stents and DES have seen improvements, yet challenges remain.

Purpose of the Study:

• To review advancements in coronary stent technology.
• To compare durable metallic and polymeric stents with emerging biodegradable stent technology.
• To discuss solutions for late restenosis and stent thrombosis.

Main Methods:

• Review of current literature on coronary stent advancements.
• Comparison of different stent types: bare metal, drug-eluting, and biodegradable.
• Analysis of stent materials, coatings, and degradation profiles.

Main Results:

• Refinements in stent alloy, strut thickness, geometry, and coatings have improved efficacy.
• Drug-eluting stents (DES) reduce restenosis but pose risks of delayed healing and late stent thrombosis.
• Biodegradable stents (polymeric and metallic) are under development to eliminate late stenting effects.

Conclusions:

• Ongoing innovation in stent technology aims to minimize adverse events associated with DES.
• Biodegradable stents offer potential for complete vessel restoration and reduced long-term complications.
• Future research focuses on optimizing stent design and materials for improved patient outcomes.